Prevalence of iatrogenic CNS inflammation at a tertiary neuroimmunology clinicHannah Kelly, Hesham Abboud, Jessica Johnson et al.|Journal of Neuroimmunology|2022Cited by 11
Real world predictors of hypogammaglobulinemia and serious infections in patients receiving ocrelizumab or ofatumumab for the treatment of multiple sclerosis: The REPLACE-MS studyKiranpal Singh Sangha, Ahmed Z Obeidat, Sara Esmaeili et al.|Multiple Sclerosis Journal|2026Cited by 1